Israeli biotech Kitov has announced that it will be ready at the end of 2016 to launch its KIT-302 treatment for osteoarthritis pain and hypertension simultaneously. Dexcel will mass-produce and market the treatment.
Osteoarthritis pain and hypertension treatment by end of year
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.